Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs Vancomycin in MRSA VAP
NCT00572559Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of linezolid in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Pfizer. Primary endpoint: Early Microbiologic Response. Started Nov 2002; status: completed.
02
Drugs
linezolid
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00572559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572559.